PL354823A1 - Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid - Google Patents

Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Info

Publication number
PL354823A1
PL354823A1 PL02354823A PL35482302A PL354823A1 PL 354823 A1 PL354823 A1 PL 354823A1 PL 02354823 A PL02354823 A PL 02354823A PL 35482302 A PL35482302 A PL 35482302A PL 354823 A1 PL354823 A1 PL 354823A1
Authority
PL
Poland
Prior art keywords
tablet
indapamide
prolonged effect
amount
total mass
Prior art date
Application number
PL02354823A
Other languages
English (en)
Other versions
PL193976B1 (pl
Inventor
Katarzyna Jureczek
Original Assignee
Pliva Kraków, Zakłady Farmaceutyczne S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Kraków, Zakłady Farmaceutyczne S.A. filed Critical Pliva Kraków, Zakłady Farmaceutyczne S.A.
Priority to PL354823A priority Critical patent/PL193976B1/pl
Priority to US10/518,386 priority patent/US7553499B2/en
Priority to EP02765720A priority patent/EP1517683B1/en
Priority to PCT/PL2002/000056 priority patent/WO2004002475A1/en
Priority to AT02765720T priority patent/ATE363903T1/de
Priority to DE60220551T priority patent/DE60220551T2/de
Publication of PL354823A1 publication Critical patent/PL354823A1/pl
Publication of PL193976B1 publication Critical patent/PL193976B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL354823A 2002-07-01 2002-07-01 Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid PL193976B1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL354823A PL193976B1 (pl) 2002-07-01 2002-07-01 Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
US10/518,386 US7553499B2 (en) 2002-07-01 2002-07-24 Sustained release tablet containing indapamide
EP02765720A EP1517683B1 (en) 2002-07-01 2002-07-24 Sustained release tablet containing indapamide
PCT/PL2002/000056 WO2004002475A1 (en) 2002-07-01 2002-07-24 Sustained release tablet containing indapamide
AT02765720T ATE363903T1 (de) 2002-07-01 2002-07-24 Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid
DE60220551T DE60220551T2 (de) 2002-07-01 2002-07-24 Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL354823A PL193976B1 (pl) 2002-07-01 2002-07-01 Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Publications (2)

Publication Number Publication Date
PL354823A1 true PL354823A1 (pl) 2004-01-12
PL193976B1 PL193976B1 (pl) 2007-04-30

Family

ID=29997631

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354823A PL193976B1 (pl) 2002-07-01 2002-07-01 Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid

Country Status (6)

Country Link
US (1) US7553499B2 (pl)
EP (1) EP1517683B1 (pl)
AT (1) ATE363903T1 (pl)
DE (1) DE60220551T2 (pl)
PL (1) PL193976B1 (pl)
WO (1) WO2004002475A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111150713A (zh) * 2018-11-07 2020-05-15 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004005009A1 (de) * 2004-01-30 2005-09-01 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
FR2878748B1 (fr) 2004-12-07 2007-03-09 Arrow Generiques Soc Par Actio Formule de comprimes permettant une liberation prolongee d'indapamide apres administration par voie orale et procede de preparation
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
RU2288713C1 (ru) * 2005-10-27 2006-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Состав пролонгированного действия, обладающий антигипертензивной и диуретической активностью, и способ его получения
CN101773500B (zh) * 2010-02-09 2012-05-23 施慧达药业集团(吉林)有限公司 抗高血压的药物组合物
US8597683B2 (en) * 2010-11-30 2013-12-03 Watson Pharmaceuticals, Inc. Modified release tranexamic acid formulation
CN103142529B (zh) * 2013-03-07 2013-12-25 宁夏康亚药业有限公司 一种吲达帕胺缓释药物组合物及其制备方法
CN105012275B (zh) * 2015-08-20 2018-03-27 广东安诺药业股份有限公司 吲达帕胺缓释剂制备方法
CN112370433A (zh) * 2020-12-07 2021-02-19 石家庄市华新药业有限责任公司 一种吲达帕胺缓释片及其制备方法
CN121606542A (zh) * 2026-02-02 2026-03-06 天津市汉康医药生物技术有限公司 一种沙库巴曲缬沙坦钠吲达帕胺缓释片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
HU196125B (en) 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
GB8502887D0 (en) * 1985-02-05 1985-03-06 Sandoz Ltd Pharmaceutical compositions
FR2677886B1 (fr) 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
EP1057479A1 (en) * 1994-12-14 2000-12-06 Enbalt Trading Limited Pharmaceutical tablet formulations for direct compression
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111150713A (zh) * 2018-11-07 2020-05-15 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法
CN111150713B (zh) * 2018-11-07 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法

Also Published As

Publication number Publication date
PL193976B1 (pl) 2007-04-30
US20050202086A1 (en) 2005-09-15
EP1517683B1 (en) 2007-06-06
EP1517683A1 (en) 2005-03-30
DE60220551D1 (de) 2007-07-19
DE60220551T2 (de) 2008-02-07
WO2004002475A1 (en) 2004-01-08
ATE363903T1 (de) 2007-06-15
US7553499B2 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
PL354823A1 (pl) Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
TW200633730A (en) Oral disintegrating dosage forms
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
DK1001748T3 (da) Fremgangsmåde til fremstilling af et granulat, som er egnet til fremstilling af i munden oplöselige tabletter, som kan sönderdeles hurtigt
MXPA04004801A (es) Proceso para preparar chicle que contiene un suplemento nutricional.
MY135183A (en) Rapidly disintegrating methylcellulose tablets
TW200510375A (en) New compounds
CA2301132A1 (en) Rapidly disintegrating methylcellulose tablets
TW200619220A (en) New hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5, 6, 7, 8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-mithoxy-n-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
MY138450A (en) Direct compression formulation and process
TW200716175A (en) Direct compression formulation and process
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
GEP20074230B (en) Phosphate prodrugs of fluorooxindoles
MX2007006322A (es) Dihidrato de clorhidrato de (s)-(-)-1-(4-fluoroisoquinolin-5-il) sulfonil-2-metil-1,4-homopiperazina.
HRP20070322T3 (hr) Tablete venlafaksin hidroklorida
SE0200154D0 (sv) New process
UA27954C2 (uk) Біологічно активна речовина фармацевтичної композиції для лікування гіперглікемій та фармацевтична композиція з протигіперглікемічною активністю
IS6919A (is) Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II
WO2004105691A3 (en) Pharmaceutical compositions for oral administration comprising lithium carbonate
ZA200506992B (en) Fibrate tablet and method for the production thereof
WO2007026261A3 (en) Formulations containing losartan and/or its salts
PT1768673E (pt) Composição farmacêutica de desintegração oral compreendendo risperidona
TW200732000A (en) Orally disintegrating table comprising fat-soluble drug
HRP20110346T1 (hr) Farmaceutski pripravak koji sadrži gabapentin

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140701